New publication in the Journal of Nuclear Medicine

We are pleased to share this new article,”Theranostics: The State of the Art”, co-authored by our Head of Nuclear Medicine, Dr Vincent Brechin, Ph.D., alongside Johannes Czernin and Ken Herrmann.

The paper explores how theranostics is transforming nuclear medicine from a primarily diagnostic specialty into a major therapeutic pillar of oncology. It reviews the key trends shaping the field, including radiopharmaceutical therapies, emerging isotopes, supply chain challenges, personalized dosimetry, combination therapies, and workforce development.

As the global nuclear medicine market continues its rapid growth, the article highlights the opportunities and challenges that will define the next decade of innovation.

Read the full article in the Journal of Nuclear Medicine: https://jnm.snmjournals.org/content/67/Supplement_2/1S

#MEDraysintell #Theranostics #NuclearMedicine #Radiopharmaceuticals #Oncology